glp-1 risks and side effects Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, effects, GLP-1 drugs: Illuminating their full

Mini-invasive Surgery

Other reported effects Beyond GI symptoms, clinical trials noted several other effects worth monitoring: Increased heart rate: A small, dose-dependent increase in resting heart rate was observed, consistent with what occurs with other GLP-1 agonists

How Pfizer stacks up against its biggest competitors For Pfizer, positive Phase 2b data for the monthly GLP-1 obesity injection is an important proof point that its late entry into weight-management drugs could still matter in a market currently led by Eli Lilly and Novo Nordisk

Low iron can restrict oxygen supply to hair follicles, leading to thinning and shedding

No, topiramate by itself is not a controlled substance

[13] How long before gut-focused changes make a difference